Hemodialysis and Peritoneal Dialysis Market Size, Share, Growth, and Industry Analysis, By Type (Hemodialysis, Peritoneal Dialysis), By Application (Home-based Dialysis, Dialysis centers & hospital-based dialysis), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET OVERVIEW

The global Hemodialysis and Peritoneal Dialysis Market size estimated at USD 101.63 billion in 2026 and is projected to reach USD 191.71 billion by 2035, growing at a CAGR of 7.31% from 2026 to 2035.

The Hemodialysis and Peritoneal Dialysis Market continues to expand due to the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). More than 850 million people worldwide are affected by kidney-related disorders, while over 4 million patients receive dialysis treatment globally. Hemodialysis accounts for approximately 88% of total dialysis procedures, while peritoneal dialysis represents nearly 12%. More than 160,000 dialysis machines are actively deployed across healthcare facilities worldwide. Increasing life expectancy, which reached 73 years globally in 2024, has contributed to a larger patient pool requiring renal replacement therapy. Technological advancements in dialysis membranes, portable systems, and automated peritoneal dialysis devices continue to shape the Hemodialysis and Peritoneal Dialysis Market.

The United States remains the largest contributor to the Hemodialysis and Peritoneal Dialysis Market. More than 808,000 individuals in the country are living with kidney failure, while approximately 557,000 patients undergo dialysis treatment. Hemodialysis represents nearly 85% of dialysis procedures conducted in the U.S., whereas peritoneal dialysis accounts for about 15%. More than 7,800 dialysis centers operate nationwide, supporting a growing treatment population. Around 37 million American adults have chronic kidney disease, representing nearly 15% of the adult population. Medicare finances dialysis treatment for over 500,000 patients annually, highlighting the substantial healthcare infrastructure supporting renal care services across the nation.

KEY FINDINGS

LATEST TRENDS

The Hemodialysis and Peritoneal Dialysis Market is witnessing significant transformation through technological innovation and changing treatment preferences. Home dialysis adoption has accelerated, with nearly 14% of dialysis patients in developed nations now receiving treatment outside conventional clinical settings. Automated peritoneal dialysis devices account for approximately 42% of all peritoneal dialysis procedures globally, reflecting strong acceptance of user-friendly systems.

Portable hemodialysis equipment has gained traction, with device installations increasing by 17% during the past two years. Remote patient monitoring solutions are integrated into nearly 29% of newly installed dialysis systems, enabling healthcare professionals to monitor treatment adherence and patient health indicators in real time. High-flux dialyzers now represent over 65% of hemodialysis consumable usage due to superior toxin removal performance.

MARKET DYNAMICS

Driver

Rising prevalence of chronic kidney disease and end-stage renal disease.

Chronic kidney disease affects more than 850 million people globally, making it one of the most significant contributors to dialysis demand. Approximately 10% of the world's population experiences some degree of kidney dysfunction. More than 4 million patients currently rely on dialysis treatment, and the number continues to rise due to increasing diabetes and hypertension prevalence. Diabetes contributes to nearly 38% of new kidney failure cases, while hypertension accounts for approximately 26%. The global population aged 65 years and older surpassed 771 million individuals, creating a larger pool of patients susceptible to renal complications.

Restraint

High treatment burden and patient complications.

Dialysis treatment remains associated with significant clinical and logistical challenges. Approximately 28% of hemodialysis patients experience vascular access complications annually. Treatment sessions typically require three visits per week and four hours per session, limiting patient flexibility. Infection rates among dialysis patients remain close to 15% annually, while cardiovascular complications affect nearly 45% of long-term dialysis users. Peritoneal dialysis patients experience peritonitis incidence rates of approximately 0.25 episodes per patient-year.

Expansion of home-based and digitally connected dialysis solutions

Opportunity

Home-based dialysis represents one of the most promising growth opportunities within the Hemodialysis and Peritoneal Dialysis Market. Currently, only 10% of dialysis patients receive treatment at home, indicating substantial expansion potential. Studies demonstrate that home dialysis can improve treatment adherence by 24% and patient satisfaction by 31%.

Remote monitoring technologies enable clinicians to track treatment parameters in real time, reducing emergency interventions by approximately 18%. Automated peritoneal dialysis devices are used by more than 40% of peritoneal dialysis patients and continue to gain acceptance.

Shortage of nephrology professionals and infrastructure disparities

Challenge

The global nephrology workforce remains insufficient to meet rising treatment demand. Several countries report nephrologist-to-patient ratios below 1 specialist per 1,000 dialysis patients. Rural regions often experience dialysis center shortages exceeding 30% relative to patient needs.

More than 2 million individuals requiring renal replacement therapy remain untreated annually due to limited infrastructure access. Equipment maintenance costs contribute significantly to operational challenges, with dialysis machines requiring servicing after approximately 5,000 treatment hours.

•   
•   
  

  Download Free Sample to learn more about this report

    

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SEGMENTATION

By Type

• Hemodialysis: Hemodialysis remains the dominant segment within the Hemodialysis and Peritoneal Dialysis Market, accounting for approximately 88% of total treatment volume. More than 3.5 million patients worldwide undergo hemodialysis therapy. Standard treatment schedules involve three sessions per week, resulting in approximately 156 procedures per patient annually. High-flux dialyzers represent over 65% of consumables used in this segment. More than 160,000 dialysis machines are operational globally, with hospitals and specialized dialysis centers serving as primary treatment locations.

• Peritoneal Dialysis: Peritoneal dialysis accounts for approximately 12% of the Hemodialysis and Peritoneal Dialysis Market and serves more than 500,000 patients globally. Continuous ambulatory peritoneal dialysis represents nearly 58% of procedures within this segment, while automated peritoneal dialysis contributes 42%. Home treatment capability remains a major advantage, reducing facility visits by over 80% compared with conventional hemodialysis schedules. Patient independence and flexible treatment timing have improved adoption rates by approximately 15% in several developed healthcare systems.

By Application

• Home-based Dialysis: Home-based dialysis accounts for approximately 10% of the Hemodialysis and Peritoneal Dialysis Market. More than 400,000 patients globally receive dialysis therapy at home. Automated peritoneal dialysis dominates this application, representing nearly 70% of home-based treatments. Studies indicate that home dialysis improves patient satisfaction by approximately 31% and reduces transportation requirements by over 90%. Remote monitoring systems are utilized in nearly 35% of home dialysis programs. Government-supported initiatives have increased home dialysis enrollment by approximately 16% across several healthcare systems.

• Dialysis Centers & Hospital-Based Dialysis: Dialysis centers and hospital-based dialysis account for approximately 90% of all dialysis treatments worldwide. More than 10,000 dedicated dialysis facilities operate across major healthcare markets, providing specialized renal replacement therapy services. Hemodialysis constitutes over 95% of treatments delivered within these facilities. Clinical supervision availability exceeds 99%, supporting management of complex patient conditions. Advanced monitoring systems are present in nearly 85% of modern dialysis centers. Treatment compliance rates surpass 92% due to structured scheduling and professional oversight.

•   
•   
  Download Free Sample to learn more about this report

    

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET REGIONAL OUTLOOK

• North America

North America accounts for approximately 39% of the global Hemodialysis and Peritoneal Dialysis Market. The region supports more than 650,000 dialysis patients, with the United States representing the majority. Approximately 85% of dialysis treatments in North America are performed using hemodialysis, while peritoneal dialysis contributes 15%. More than 8,000 dialysis facilities operate throughout the region.

Chronic kidney disease affects nearly 15% of adults in the United States, while diabetes prevalence exceeds 11% of the population. Canada reports more than 40,000 individuals receiving renal replacement therapy. Home dialysis adoption has increased by approximately 18% due to policy support and technological advancements.

• Europe

Europe represents approximately 27% of the Hemodialysis and Peritoneal Dialysis Market. More than 700,000 patients across the region require renal replacement therapy. Germany, France, Italy, Spain, and the United Kingdom account for over 65% of regional dialysis procedures. Hemodialysis contributes nearly 84% of treatments, while peritoneal dialysis represents approximately 16%.

The prevalence of chronic kidney disease exceeds 10% among European adults. More than 6,000 dialysis centers operate throughout the region, ensuring broad treatment accessibility. Home dialysis participation has reached approximately 13% in several Western European countries. Sustainability initiatives are gaining prominence, with newer dialysis systems reducing water consumption by over 20% per treatment cycle.

• Asia-Pacific

Asia-Pacific holds approximately 24% share of the Hemodialysis and Peritoneal Dialysis Market and contains the largest population of chronic kidney disease patients globally. More than 2 million dialysis patients reside across China, Japan, India, South Korea, and Australia. Diabetes prevalence exceeds 14% in several countries, significantly contributing to kidney disease incidence.

Japan maintains one of the highest dialysis treatment rates worldwide, with more than 340,000 active dialysis patients. China has surpassed 900,000 dialysis patients, while India continues expanding dialysis infrastructure through public healthcare initiatives. Hemodialysis accounts for approximately 90% of treatments across the region.

• Middle East & Africa

The Middle East & Africa account for approximately 10% of the Hemodialysis and Peritoneal Dialysis Market. More than 250,000 patients receive dialysis treatment across the region. Gulf Cooperation Council countries contribute a substantial portion of dialysis infrastructure investments, supporting increasing treatment accessibility.

Diabetes prevalence exceeds 16% in several Middle Eastern nations, creating a significant burden of kidney disease. Hemodialysis accounts for approximately 92% of regional treatment procedures. More than 1,500 dialysis centers operate throughout the region, with urban areas representing the majority of installations.

LIST OF TOP HEMODIALYSIS AND PERITONEAL DIALYSIS COMPANIES

• Fresenius Medical Care AG & Co. KGaA
• Integer Holdings Corporation
• Nxstage Medical, Inc
• Allmed Medical Care Holdings Limited
• Davita Healthcare Partners Inc
• Asahi Kasei Medical Co., Ltd
• Nipro Corporation
• Diaverum Deutschland GmbH
• Baxter International Inc
• Braun Melsungen AG
• Nikkiso Co., Ltd

List Of Top 2 Companies Market Share

• Fresenius Medical Care AG & Co. KGaA – approximately 32% share of global dialysis equipment and services activities, operating more than 4,000 dialysis clinics and treating over 340,000 patients annually.
• Baxter International Inc – approximately 13% share of the global dialysis market, supplying peritoneal dialysis systems to more than 100 countries and supporting over 300,000 home dialysis patients.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment activity in the Hemodialysis and Peritoneal Dialysis Market continues to focus on home-care technologies, digital health integration, and facility expansion. More than 4 million patients currently require dialysis treatment worldwide, creating substantial demand for infrastructure development. Healthcare providers have increased investment in remote monitoring platforms by approximately 21% over the past three years.

Expansion of home dialysis programs presents a significant opportunity, as only 10% of patients currently receive treatment at home. Portable dialysis equipment adoption has increased by 17%, attracting investment into compact system development. Automated peritoneal dialysis technologies continue receiving strong support due to patient convenience and reduced facility dependence.

NEW PRODUCT DEVELOPMENT

Innovation remains a key competitive factor within the Hemodialysis and Peritoneal Dialysis Market. Manufacturers are developing advanced dialysis systems designed to improve efficiency, patient comfort, and treatment personalization. New-generation dialysis machines feature digital connectivity capabilities in more than 30% of recent product launches. Portable hemodialysis systems weighing less than 35 kilograms are becoming increasingly available.

These devices enable greater mobility and support home-based treatment models. Advanced filtration membranes have improved toxin clearance efficiency by approximately 12% compared with previous-generation products. Automated peritoneal dialysis cyclers now include cloud-based monitoring platforms capable of transmitting treatment data in real time. Such systems have improved adherence rates by nearly 21%. Battery-powered emergency operation features provide additional reliability during power interruptions.

FIVE RECENT DEVELOPMENTS (2023-2025)

• In 2023, Fresenius Medical Care expanded digital dialysis monitoring capabilities across more than 4,000 clinics, improving real-time patient data management and treatment tracking.
• In 2023, Baxter International enhanced automated peritoneal dialysis systems with remote connectivity features, supporting monitoring of over 100 treatment parameters per therapy cycle.
• In 2024, Nipro Corporation introduced advanced high-flux dialyzers with approximately 12% improved middle-molecule clearance efficiency compared with previous product generations.
• In 2024, Nikkiso Co., Ltd launched upgraded dialysis machine software incorporating predictive maintenance functions that reduced equipment downtime by approximately 18%.
• In 2025, multiple leading manufacturers expanded home dialysis portfolios, contributing to a 16% increase in home-based dialysis enrollment across participating healthcare systems.

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET REPORT COVERAGE

This report provides comprehensive coverage of the Hemodialysis and Peritoneal Dialysis Market across treatment modalities, applications, technologies, end users, and geographic regions. The analysis examines more than 4 million dialysis patients worldwide and evaluates trends influencing treatment adoption and infrastructure development.

The report assesses hemodialysis, which accounts for approximately 88% of treatment volume, alongside peritoneal dialysis with a 12% share. Application analysis covers home-based dialysis and dialysis centers and hospital-based dialysis, highlighting utilization patterns and patient preferences. Market dynamics are evaluated through key growth drivers, restraints, opportunities, and challenges supported by quantitative indicators.